Why Moderna Stock Surged Today
Shares of Moderna (NASDAQ: MRNA) popped on Wednesday after the biotech leader announced positive clinical trial results for its experimental skin cancer vaccine, developed with healthcare giant .
By the close of trading, Moderna's stock price was up more than 15%.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€35.23
1.430%
Our community is currently low on Moderna Inc. with 7 Buy predictions and 10 Sell predictions.
A potential of -40.38%, resulting from comparing the current price of 35.23 € with the target price of 21 € for Moderna Inc., shows the chance of incurring significant losses.
